Avery Biomedical Devices, manufacturer of the Avery Breathing
Pacemaker System, has named Dilys M. Gore, Ph.D. as its Chief Science
Dr. Gore is a Ph.D. qualified bioengineer with over 30 years of
experience with Avery Breathing Pacemakers and other medical devices.
As Chief Science Officer, Dr. Gore, in addition to her current
responsibilities as European Manager, will lead the company research
and development efforts.
Dr. Gore states, "I am thrilled to be able to further contribute to
the growth of ABD."
"We are honored to have Dr. Gore lead our efforts in future product
development," noted Linda Towler, CEO of Avery Biomedical Devices.
"Her scientific experience and expertise will be invaluable in our
continued efforts to best serve those who benefit from our products."
About Breathing Pacemakers
An Avery Breathing Pacemaker is a surgically implanted phrenic nerve,
or diaphragm, stimulator. It provides a far lower cost of care and a
much higher quality of life for ventilator dependent patients with
quadriplegia, central sleep apnea and diaphragm paralysis.
Avery Breathing Pacemakers are the only diaphragm pacing system to
have full premarket approval by the US FDA for adult and pediatric
use. By using implanted radiofrequency receivers and external
antennas, Avery Breathing Pacemakers do not have percutaneous
connectors which can result in chronic infections and ongoing wound
management issues for caregivers.
Avery Biomedical Devices, Inc. is a privately-held company located on
Long Island, New York. It manufactures the Avery Breathing Pacemaker:
an implanted phrenic nerve stimulator which is used to free many
quadriplegic and central hypoventilation patients from mechanical
ABD is ISO-9001 certified, ISO-13485 compliant, and an FDA registered
manufacturer of Class III medical devices.
Should you know a patient with quadriplegia, central sleep apnea,
diaphragm paralysis or other condition that may benefit from an Avery
Breathing Pacemaker please contact us.